No evidence related to transferability of biomarker tests for decision-making on chemotherapy for breast cancer

Following a benefit assessment in 2016 and an addendum in 2018, the German Institute for Quality and Efficiency in Health Care has again examined biomarker-based tests for women with primary breast cancer.
Read More